Evidence map›Paper›PMID 22258163›Full record

ArticleJournal of visualized experiments : JoVE2012

In vitro assembly of semi-artificial molecular machine and its use for detection of DNA damage.

Candace L Minchew, Vladimir V Didenko

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Express FRET Labeling and Analysis of Phagocytic Clearance.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  2. Quick Detection of DNase II-Type Breaks in Formalin-Fixed Tissue Sections.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Candace L MinchewNeurosurgery, Baylor College of Medicine.
Vladimir V Didenko
Baylor College of Medicine · US

Funding

Ligatable fluorescent probes using energy transfer for apoptosis detectionR01NS062842 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2009 to 2012
$994k
Semi-artificial nanomachines for detection of DNA damage and apoptosisR21EB006301 · NIBIB · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2006 to 2008
$487k
Assay for dual detection of apoptosisR21NS064403 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2009 to 2010
$409k
NIBIB NIH HHS R21 EB006301NINDS NIH HHS R01 NS062842NINDS NIH HHS R01NS062842NINDS NIH HHS R21 NS064403
6 · The paper itself

Abstract

Naturally occurring bio-molecular machines work in every living cell and display a variety of designs. Yet the development of artificial molecular machines centers on devices capable of directional motion, i.e. molecular motors, and on their scaled-down mechanical parts (wheels, axels, pendants etc). This imitates the macro-machines, even though the physical properties essential for these devices, such as inertia and momentum conservation, are not usable in the nanoworld environments. Alternative designs, which do not follow the mechanical macromachines schemes and use mechanisms developed in the evolution of biological molecules, can take advantage of the specific conditions of the nanoworld. Besides, adapting actual biological molecules for the purposes of nano-design reduces potential dangers the nanotechnology products may pose. Here we demonstrate the assembly and application of one such bio-enabled construct, a semi-artificial molecular device which combines a naturally-occurring molecular machine with artificial components. From the enzymology point of view, our construct is a designer fluorescent enzyme-substrate complex put together to perform a specific useful function. This assembly is by definition a molecular machine, as it contains one. Yet, its integration with the engineered part - fluorescent dual hairpin - re-directs it to a new task of labeling DNA damage. Our construct assembles out of a 32-mer DNA and an enzyme vaccinia topoisomerase I (VACC TOPO). The machine then uses its own material to fabricate two fluorescently labeled detector units (Figure 1). One of the units (green fluorescence) carries VACC TOPO covalently attached to its 3'end and another unit (red fluorescence) is a free hairpin with a terminal 3'OH. The units are short-lived and quickly reassemble back into the original construct, which subsequently recleaves. In the absence of DNA breaks these two units continuously separate and religate in a cyclic manner. In tissue sections with DNA damage, the topoisomerase-carrying detector unit selectively attaches to blunt-ended DNA breaks with 5'OH (DNase II-type breaks), fluorescently labeling them. The second, enzyme-free hairpin formed after oligonucleotide cleavage, will ligate to a 5'PO(4) blunt-ended break (DNase I-type breaks), if T4 DNA ligase is present in the solution. When T4 DNA ligase is added to a tissue section or a solution containing DNA with 5'PO(4) blunt-ended breaks, the ligase reacts with 5'PO(4) DNA ends, forming semi-stable enzyme-DNA complexes. The blunt ended hairpins will interact with these complexes releasing ligase and covalently linking hairpins to DNA, thus labeling 5'PO(4) blunt-ended DNA breaks. This development exemplifies a new practical approach to the design of molecular machines and provides a useful sensor for detection of apoptosis and DNA damage in fixed cells and tissues.

Indexed as

DNA DamageDNADNA LigasesDNA Topoisomerases, Type IGreen Fluorescent ProteinsVacciniaDNADNA LigasesDNA Topoisomerases, Type IGreen Fluorescent Proteins

Identifiers

PMID22258163
PMCPMC3353514
OpenAlexW2138097294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.